0001209191-22-044465.txt : 20220804
0001209191-22-044465.hdr.sgml : 20220804
20220804203955
ACCESSION NUMBER: 0001209191-22-044465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220802
FILED AS OF DATE: 20220804
DATE AS OF CHANGE: 20220804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perfetti Riccardo
CENTRAL INDEX KEY: 0001775410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 221138328
MAIL ADDRESS:
STREET 1: C/O APPLIED THERAPEUTICS, INC.
STREET 2: 340 MADISON AVENUE, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-02
0
0001697532
Applied Therapeutics Inc.
APLT
0001775410
Perfetti Riccardo
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK
NY
10017
0
1
0
0
Chief Medical Officer
Employee Stock Option (Right to Buy)
2.02
2022-08-02
4
D
0
50000
D
2032-04-13
Common Stock
50000
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
50000
A
2032-04-13
Common Stock
50000
50000
D
Employee Stock Option (Right to Buy)
4.17
2022-08-02
4
D
0
32100
D
2032-01-07
Common Stock
32100
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
32100
A
2032-01-07
Common Stock
32100
32100
D
Employee Stock Option (Right to Buy)
9.44
2022-08-02
4
D
0
32100
D
2031-12-14
Common Stock
32100
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
32100
A
2031-12-14
Common Stock
32100
32100
D
Employee Stock Option (Right to Buy)
23.15
2022-08-02
4
D
0
36495
D
2030-12-10
Common Stock
36495
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
36495
A
2030-12-10
Common Stock
36495
36495
D
Employee Stock Option (Right to Buy)
22.20
2022-08-02
4
D
0
51666
D
2029-12-16
Common Stock
51666
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
51666
A
2029-12-16
Common Stock
51666
51666
D
Employee Stock Option (Right to Buy)
10.00
2022-08-02
4
D
0
134997
D
2029-05-12
Common Stock
134997
0
D
Employee Stock Option (Right to Buy)
1.05
2022-08-02
4
D
0
134997
A
2029-05-12
Common Stock
134997
134997
D
The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Reflects an initial grant of 32,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Reflects an initial grant of 32,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Reflects an initial grant of 36,495 Options granted on December 10, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Reflects an initial grant of 51,666 Options granted on December 16, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 16, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Reflects an initial grant of 170,522 Options granted on May 13, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on May 13, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Shoshana Shendelman, as attorney-in-fact
2022-08-04